A Multicenter, Randomized, Open-label, Prospective Study to Estimate the add-on Effects of Memantine as Ebixa Oral Pump on Language in Moderate to Severe Alzheimer's Disease Patients Already Receiving Donepezil.
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Memantine (Primary) ; Donepezil
- Indications Alzheimer's disease
- Focus Therapeutic Use
- Acronyms ROMEO-AD
- 12 Aug 2014 According to the ClinicalTrials.gov record, planned end date changed from 1 Mar 2015 to 1 Aug 2015.
- 15 May 2013 New trial record